$1.21
-0.04-3.20%
At Close: -
$1.22
0.00970.80%
After Hours: Aug 23, 7:58 PM EDT
15 minutes delayed
Comments
Loading...
Revelation Biosciences (REVB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRevelation Biosciences (NASDAQ:REVB) Stock Quotes, Forecast and News Summary
Revelation Biosciences Stock (NASDAQ: REVB) stock price, news, charts, stock research, profile.
| Open | $1.30 |
| Close | $1.21 |
| Volume / Avg. | 1.47M / 2.08M |
| Day Range | $1.12 - $1.30 |
| 52 Wk Range | 0.81 - 28.20 |
| Market Cap | $2.00M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 48 |
| Short Interest | 2.56% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Revelation Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of t...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Revelation Biosciences (REVB) stock?
You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.
Who are Revelation Biosciences (REVB) competitors?
Other companies in Revelation Biosciences’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG) and Entero Therapeutics (NASDAQ:ENTO).
What is the forecast, or price target, for Revelation Biosciences (REVB) stock?
Revelation Biosciences has a consensus price target of $13.50.
What is the current price for Revelation Biosciences (REVB)?
The stock price for Revelation Biosciences (NASDAQ: REVB) is $1.2197 last updated August 23, 2024 at 7:58 PM EDT.
Does Revelation Biosciences (REVB) pay a dividend?
There are no upcoming dividends for Revelation Biosciences.
When is Revelation Biosciences (NASDAQ:REVB) reporting earnings?
Revelation Biosciences’s Q3 earnings are confirmed for Monday, November 11, 2024.
Is Revelation Biosciences (REVB) going to split?
There is no upcoming split for Revelation Biosciences.
What sector and industry does Revelation Biosciences (REVB) operate in?
Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.